🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

59,53 USD

Máx. histórico

2.925,00

12010 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,96%

Rango 52 semanas

37,06 – 95,49

Variación hoy

-0,07%

Cierre anterior

59,57

Rango de hoy

59,25 – 60,89

Volumen hoy

1.327.132

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,88%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 13 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/10/2024 21,09 21,17 19,81 20,49 -3,26% 6,45% 1.207.100
18/10/2024 20,95 21,25 20,62 21,18 +1,63% 3,01% 1.038.300
17/10/2024 21,10 21,44 20,65 20,84 -1,23% 3,74% 1.658.100
16/10/2024 19,98 21,12 19,91 21,10 +6,14% 6,08% 1.677.100
15/10/2024 19,52 19,94 19,44 19,88 +2,69% 2,56% 1.027.700
14/10/2024 18,50 19,40 18,40 19,36 +4,99% 5,41% 870.700
11/10/2024 17,64 18,47 17,52 18,44 +4,18% 5,39% 967.400
10/10/2024 17,55 17,84 17,05 17,70 -0,78% 4,50% 1.305.200
09/10/2024 18,01 18,12 17,53 17,84 -1,00% 3,28% 1.042.800
08/10/2024 18,13 18,33 17,85 18,02 -0,61% 2,65% 1.206.000
07/10/2024 18,74 18,89 17,83 18,13 -3,67% 5,63% 1.115.700
04/10/2024 19,01 19,27 18,68 18,82 -0,16% 3,10% 669.400
03/10/2024 18,95 19,25 18,73 18,85 -1,93% 2,74% 790.700
02/10/2024 19,01 19,43 18,60 19,22 +0,21% 4,37% 781.700
01/10/2024 19,20 19,36 18,15 19,18 -0,98% 6,28% 1.469.000
30/09/2024 19,33 19,76 19,10 19,37 -1,53% 3,41% 1.777.400
27/09/2024 19,96 20,03 19,54 19,67 +0,25% 2,45% 834.300
26/09/2024 19,69 20,11 19,07 19,62 +1,03% 5,26% 1.041.900
25/09/2024 20,23 20,35 19,38 19,42 -3,57% 4,77% 931.600
24/09/2024 20,01 20,55 19,84 20,14 +0,70% 3,55% 803.700
23/09/2024 20,85 20,85 19,99 20,00 -3,85% 4,12% 987.100
20/09/2024 21,20 21,24 20,75 20,80 -1,61% 2,31% 2.046.400
19/09/2024 21,47 22,13 20,99 21,14 +1,73% 5,31% 951.600
18/09/2024 20,00 21,36 19,79 20,78 +3,85% 7,85% 1.551.800
17/09/2024 20,60 20,71 19,44 20,01 -2,15% 6,17% 2.169.800
16/09/2024 21,50 21,73 20,41 20,45 -4,84% 6,16% 947.100
13/09/2024 20,39 21,90 20,39 21,49 +6,20% 7,41% 1.516.300
12/09/2024 20,90 21,10 20,14 20,24 -3,37% 4,59% 1.066.500
11/09/2024 21,32 21,32 20,63 20,94 -2,47% 3,24% 1.422.300
10/09/2024 22,00 22,23 21,38 21,47 -1,33% 3,88% 1.053.100